Literature DB >> 20940104

Spectroscopic investigations and quantum chemical computational study of (E)-4-methoxy-2-[(p-tolylimino)methyl]phenol.

Basak Kosar1, Cigdem Albayrak.   

Abstract

In this work the electronic structure of (E)-4-methoxy-2-[(p-tolylimino)methyl]phenol has been characterized by the B3LYP/6-31G(d) level by using density functional theory. The experimental infrared and electronic absorption spectra have been obtained and compared with the theoretically obtained ones. Molecular electrostatic potential map has been evaluated; natural bond orbital and frontier molecular orbitals analysis have been performed from the optimized geometry. The energetic behavior of the title compound has been examined in solvent media using polarizable continuum model. The non-linear optical properties have been computed with the same level of theory. In addition, the changes of thermodynamic properties have been obtained in the range of 100-500 K. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20940104     DOI: 10.1016/j.saa.2010.09.016

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  15 in total

1.  Conjugation in multi-tetrazole derivatives: a new design direction for energetic materials.

Authors:  Shuyang Sun; Ming Lu
Journal:  J Mol Model       Date:  2018-06-23       Impact factor: 1.810

2.  Spectral and molecular modeling studies on hydroxybenzaldehydes with native and modified cyclodextrins.

Authors:  M Jude Jenita; T Mohandass; N Rajendiran
Journal:  J Fluoresc       Date:  2013-12-06       Impact factor: 2.217

3.  Synthesis, characterization, and computational study of a new dimethoxy-chalcone.

Authors:  Ricardo R Ternavisk; Ademir J Camargo; Francisco B C Machado; José A F F Rocco; Gilberto L B Aquino; Valter H C Silva; Hamilton B Napolitano
Journal:  J Mol Model       Date:  2014-11-25       Impact factor: 1.810

4.  In silico drug repurposing for coronavirus (COVID-19): screening known HCV drugs against the SARS-CoV-2 spike protein bound to angiotensin-converting enzyme 2 (ACE2) (6M0J).

Authors:  Konstantinos G Kalamatianos
Journal:  Mol Divers       Date:  2022-06-23       Impact factor: 3.364

5.  Structural elucidation and molecular docking of ferulic acid from Parthenium hysterophorus possessing COX-2 inhibition activity.

Authors:  Naresh Kumar; Vikas Pruthi
Journal:  3 Biotech       Date:  2014-10-07       Impact factor: 2.406

6.  DFT and molecular docking study of chloroquine derivatives as antiviral to coronavirus COVID-19.

Authors:  Olfa Noureddine; Noureddine Issaoui; Omar Al-Dossary
Journal:  J King Saud Univ Sci       Date:  2020-11-25

7.  Crystal, spectroscopic and quantum mechanics studies of Schiff bases derived from 4-nitrocinnamaldehyde.

Authors:  Friday E Ani; Collins U Ibeji; Nnamdi L Obasi; Monsuru T Kelani; Kingsley Ukogu; Gideon F Tolufashe; Segun A Ogundare; Oluwatoba E Oyeneyin; Glenn E M Maguire; Hendrik G Kruger
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

8.  (E)-1,3-Bis(anthracen-9-yl)prop-2-en-1-one: crystal structure and DFT study.

Authors:  Dian Alwani Zainuri; Ibrahim Abdul Razak; Suhana Arshad
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-03-09

9.  Anticancer Indole-Based Chalcones: A Structural and Theoretical Analysis.

Authors:  Farid A Badria; Saied M Soliman; Saleh Atef; Mohammad Shahidul Islam; Abdullah Mohammed Al-Majid; Necmi Dege; Hazem A Ghabbour; M Ali; Fardous F El-Senduny; Assem Barakat
Journal:  Molecules       Date:  2019-10-16       Impact factor: 4.411

10.  Synthesis, Characterization, Catalytic Activity, and DFT Calculations of Zn(II) Hydrazone Complexes.

Authors:  Temiloluwa T Adejumo; Nikolaos V Tzouras; Leandros P Zorba; Dušanka Radanović; Andrej Pevec; Sonja Grubišić; Dragana Mitić; Katarina K Anđelković; Georgios C Vougioukalakis; Božidar Čobeljić; Iztok Turel
Journal:  Molecules       Date:  2020-09-04       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.